Dr. Stern. "LymPro can improve upon the accuracy of AD diagnosis during life, providing clinical investigators the ability to enroll appropriate patients into research studies. LymPro's use as a diagnostic tool for clinical research has the potential to change the paradigm of pharmaceutical clinical studies in AD and ultimately other neurological related trials."